| 貨號(hào) | 規(guī)格 | 價(jià)格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
S81497-2mg |
99.9% | ￥272.00 | 5 | - | - | - |
|
S81497-5mg |
99.9% | ￥340.00 | 6 | - | - | - |
|
S81497-10mg |
99.9% | ￥586.50 | 4 | - | - | - |
|
S81497-25mg |
99.9% | ￥1122.00 | 6 | - | - | - |
|
S81497-50mg |
99.9% | ￥1955.00 | 5 | - | - | - |
|
S81497-100mg |
≥95% | ￥2975.00 | 貨期：2-3天 | - | - | - |
|
S81497-200mg |
≥95% | ￥5525.00 | 貨期：2-3天 | - | - | - |
|
ZCL278 is a selective Cdc42 modulator that directly binds to Cdc42 and inhibits its functions with Kd of 11.4 μM for Cdc42-ZCL278 affinity in surface plasmon resonance (SPR) experiment.
| 產(chǎn)品描述： | ZCL278 is a selective Cdc42 modulator that directly binds to Cdc42 and inhibits its functions with Kd of 11.4 μM for Cdc42-ZCL278 affinity in surface plasmon resonance (SPR) experiment. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點(diǎn)： | Kd: 11.4 μM (Cdc42);CDK;?Ras | ||||||||||||||||||||
| 體內(nèi)研究： | ZCL278 reduces the JUNV RNA load in the spleen more than 33-fold, with JUNV RNA being undetectable in 5 out of 8 mice. These results are similar to those seen in Gabapentin-treated mice, demonstrating that ZCL278 can abrogate JUNV replication | ||||||||||||||||||||
| 參考文獻(xiàn)： | 1. Friesland A, et al. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1261-6. 2. Chou YY, et al. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor. J Virol. 2016 Apr 14;90(9):4494-510. | ||||||||||||||||||||
| 溶解性： | DMSO : 50 mg/mL (85.49 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號(hào)
危險(xiǎn)品化學(xué)品經(jīng)營(yíng)許可證（不帶存儲(chǔ)）
營(yíng)業(yè)執(zhí)照(三證合一)
北京